Evidence map›Paper›PMID 26856373›Full record

ArticleScientific reports2016

Internal (His)₆-tagging delivers a fully functional hetero-oligomeric class II chaperonin in high yield.

Danielle M Paul, Fabienne Beuron, Richard B Sessions, Andrea Brancaccio, Maria Giulia Bigotti

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Intraring allostery controls the function and assembly of a hetero-oligomeric class II chaperonin.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Danielle M PaulSchool of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol BS8 1TD, UK.
Fabienne BeuronDivision of Structural Biology, The Institute of Cancer Research, London SW7 3RP, UK.
Richard B SessionsSchool of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.
Andrea BrancaccioSchool of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.
Maria Giulia BigottiSchool of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.
University of Bristol · GBInstitute of Cancer Research · GBInstitute of Chemistry of Molecular Recognition · IT

Funding

British Heart Foundation FS/14/18/30711Wellcome Trust
6 · The paper itself

Abstract

Group II chaperonins are ATP-ases indispensable for the folding of many proteins that play a crucial role in Archaea and Eukarya. They display a conserved two-ringed assembly enclosing an internal chamber where newly translated or misfolded polypeptides can fold to their native structure. They are mainly hexadecamers, with each eight-membered ring composed of one or two (in Archaea) or eight (in Eukarya) different subunits. A major recurring problem within group II chaperonin research, especially with the hetero-oligomeric forms, is to establish an efficient recombinant system for the expression of large amounts of wild-type as well as mutated variants. Herein we show how we can produce, in E. coli cells, unprecedented amounts of correctly assembled and active αβ-thermosome, the class II chaperonin from Thermoplasma acidophilum, by introducing a (His)6-tag within a loop in the α subunit of the complex. The specific location was identified via a rational approach and proved not to disturb the structure of the chaperonin, as demonstrated by size-exclusion chromatography, native gel electrophoresis and electron microscopy. Likewise, the tagged protein showed an ATP-ase activity and an ability to refold substrates identical to the wild type. This tagging strategy might be employed for the overexpression of other recombinant chaperonins.

Indexed as

Archaeal ProteinsGroup II ChaperoninsHistidineRecombinant Fusion ProteinsThermoplasmaArchaeal ProteinsGroup II ChaperoninsHistidinepolyhistidineRecombinant Fusion Proteins

Identifiers

PMID26856373
PMCPMC4746591
OpenAlexW2286001653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.